Skip to content

Live Events
Sign Up / Login

Live Events
Sign Up / Login

MEC Plus Full List View

By pinki@katapult.biz / February 16, 2025

MEC Plus

Speciality

Author / Speaker

Title

Type of Media

Events

Search Entries:

Clear

«
1
…
68
69
70
71
72
…
115
»

Targeted Therapy for Colon Cancer: What is New?

Targeted Therapy for Colon Cancer: What is New?

Benjamin A. Weinberg, MD, FACP

Developments in Gastric, and Esophageal Tumors

Developments in Gastric, and Esophageal Tumors

Mike Cusnir, MD

Immunotherapy for GU Malignancies and Exciting Developments

Immunotherapy for GU Malignancies and Exciting Developments

Rohit Jain, MD, MPH

Immunotherapy for GYO Malignancies: Is There Still Time for Progress?

Immunotherapy for GYO Malignancies: Is There Still Time for Progress?

Mark Shahin, MD, FACOG, FACS

Establishing IO Management in Gastrointestinal Cancers

Establishing IO Management in Gastrointestinal Cancers

Richard Kim, MD

New Developments in Melanoma Early and Late Stage

New Developments in Melanoma Early and Late Stage

Sanjiv Agarwala, MD

Immunotherapy for Early-Stage Lung Cancer: Adjuvant and Neoadjuvant Approaches

Immunotherapy for Early-Stage Lung Cancer: Adjuvant and Neoadjuvant Approaches

Luis E. Raez, MD, FACP, FCCP

Disparities in Breast Cancer Therapy Outcomes

Disparities in Breast Cancer Therapy Outcomes

Gerardo Colon-Otero, MD

Challenges in Her-2 Breast Cancer

Challenges in Her-2 Breast Cancer

Reshma Mahtani, DO

Guidelines for Hormone Therapy in Breast Cancer

Guidelines for Hormone Therapy in Breast Cancer

Noridza Rivera-Rodriguez, MD

TNBC and Immunotherapy Developments in Breast Cancer

TNBC and Immunotherapy Developments in Breast Cancer

Mariana Chavez-McGregor, MD, MSc

Liquid Biopsy

Christian Rolfo MD, PhD, MBA, Dr.Hc.

Anticoagulation in the Oncology Patient

Anticoagulation in the Oncology Patient

Pamela B. Dudkiewicz, DNP, ARNP-BC, AOCNP

How Far Have We Gone with Biosimilars?

How Far Have We Gone with Biosimilars?

Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE

Current Status of Cervical Cancer Screening

Current Status of Cervical Cancer Screening

Ritu Salani MD, MBA

Role of ADCs in Gynecological Malignancies

Role of ADCs in Gynecological Malignancies

Don S. Dizon, MD, FACP, FASCO

Ovarian Cancer: Beyond Carboplatin and Paclitaxel

Ovarian Cancer: Beyond Carboplatin and Paclitaxel

Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS

Endocrine Therapy for Advanced Breast Cancer: Current and Future Strategies

Endocrine Therapy for Advanced Breast Cancer: Current and Future Strategies

Reshma L. Mahtani, DO

Endocrine Therapy and Targeted Agents for Early-Stage HR+ Breast Cancer

Endocrine Therapy and Targeted Agents for Early-Stage HR+ Breast Cancer

William J. Gradishar, MD, FACP

Antibody Drug Conjugates: New Agents and Optimal Sequencing

Antibody Drug Conjugates: New Agents and Optimal Sequencing

Hope S. Rugo, MD, FASCO

Immunotherapy for Breast Cancer: Updates and New Directions

Immunotherapy for Breast Cancer: Updates and New Directions

Mark Pegram, MD

Prostate Cancer: Role of PSMA PET and Accurately Defining “Neuroendocrine” Prostate

Prostate Cancer: Role of PSMA PET and Accurately Defining “Neuroendocrine” Prostate

Ravi A. Madan, MD

Role of Immunotherapy in HNC

Role of Immunotherapy in HNC

Hyunseok (Hyu) Kang, MD, MPH, FACP

Renal Cell Carcinoma (RCC): Current Approach to First Line Therapy and Beyond

Renal Cell Carcinoma (RCC): Current Approach to First Line Therapy and Beyond

Petros Grivas, MD, PhD

Adjuvant and Neo-adjuvant Therapy for Lung Cancer

Adjuvant and Neo-adjuvant Therapy for Lung Cancer

Janakiraman Subramanian MD, MPH

Displaying 1,726 - 1,750 of 2,875

Post navigation

← Previous View

6619 South Dixie Highway #341
Miami, FL 33143

Phone: 305.663.1628
Email: info@meccinc.com

Useful Links

Library
Live Events

Categories

MEC Basic
MEC Plus
Purchased

About Us

Why Subscribe
About Us
Accreditation

© 2025 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok